{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:56:26Z","timestamp":1740149786279,"version":"3.37.3"},"reference-count":139,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T00:00:00Z","timestamp":1591142400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T00:00:00Z","timestamp":1591142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Barrett\u2019s oesophagus is the only known precursor to oesophageal adenocarcinoma (OAC). Although guidelines on the screening and surveillance exist in Barrett\u2019s oesophagus, the current strategies are inadequate. Oesophagogastroduodenoscopy (OGD) is the gold standard method in screening for Barrett\u2019s oesophagus. This invasive method is expensive with associated risks negating its use as a current screening tool for Barrett\u2019s oesophagus. This review explores current definitions, epidemiology, biomarkers, surveillance, and screening in Barrett\u2019s oesophagus. Imaging modalities applicable to this condition are discussed, in addition to future developments. There is an urgent need for an alternative non-invasive method of screening and\/or surveillance which could be highly beneficial towards reducing waiting times, alleviating patient fears and reducing future costs in current healthcare services. Vibrational spectroscopy has been shown to be promising in categorising Barrett\u2019s oesophagus through to high-grade dysplasia (HGD) and OAC. These techniques need further validation through multicentre trials.<\/jats:p>","DOI":"10.1007\/s12328-020-01135-2","type":"journal-article","created":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T15:31:10Z","timestamp":1591198270000},"page":"635-649","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Towards screening Barrett\u2019s oesophagus: current guidelines, imaging modalities and future developments"],"prefix":"10.1007","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4384-218X","authenticated-orcid":false,"given":"Ishaan","family":"Maitra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravindra Sudhachandra","family":"Date","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis Luke","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,3]]},"reference":[{"key":"1135_CR1","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/jnci\/dji024","volume":"97","author":"H Pohl","year":"2005","unstructured":"Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst. 2005;97:142\u20136.","journal-title":"J Natl Cancer Inst"},{"key":"1135_CR2","first-page":"2","volume":"26","author":"WJ Blot","year":"1999","unstructured":"Blot WJ, McLaughlin JK. The changing epidemiology of esophageal cancer. Semin Oncol. 1999;26:2\u20138.","journal-title":"Semin Oncol"},{"key":"1135_CR3","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1136\/gut.2007.145177","volume":"57","author":"RM Zagari","year":"2008","unstructured":"Zagari RM, Fuccio L, Wallander MA, et al. Gastro-oesophageal reflux symptoms, oesophagitis and Barrett\u2019s oesophagus in the general population: the Loiano\u2013Monghidoro study. Gut. 2008;57:1354\u20139.","journal-title":"Gut"},{"key":"1135_CR4","first-page":"2187","volume":"73","author":"JC Layke","year":"2006","unstructured":"Layke JC, Lopez PP. Esophageal cancer: a review and update. Am Fam Phys. 2006;73:2187\u201394.","journal-title":"Am Fam Phys"},{"key":"1135_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1542-3565(04)00602-0","volume":"3","author":"A Wong","year":"2005","unstructured":"Wong A, Fitzgerald RC. Epidemiologic risk factors for Barrett\u2019s esophagus and associated adenocarcinoma. Clin Gastroenterol Hepatol. 2005;3:1\u201310.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1135_CR6","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1053\/j.gastro.2005.08.053","volume":"129","author":"J Ronkainen","year":"2005","unstructured":"Ronkainen J, Aro P, Storskrubb T, et al. Prevalence of Barrett\u2019s esophagus in the general population: an endoscopic study. Gastroenterology. 2005;129:1825\u201331.","journal-title":"Gastroenterology"},{"key":"1135_CR7","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1136\/gutjnl-2011-300730","volume":"61","author":"TK Desai","year":"2012","unstructured":"Desai TK, Krishnan K, Samala N, et al. The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett\u2019s oesophagus: a meta-analysis. Gut. 2012;61:970\u20136.","journal-title":"Gut"},{"key":"1135_CR8","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.gie.2013.07.046","volume":"79","author":"LG Gordon","year":"2014","unstructured":"Gordon LG, Mayne GC, Hirst NG, et al. Cost-effectiveness of endoscopic surveillance of non-dysplastic Barrett\u2019s esophagus. Gastrointest Endosc. 2014;79:242\u201352.","journal-title":"Gastrointest Endosc"},{"key":"1135_CR9","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1053\/j.gastro.2011.01.031","volume":"140","author":"SJ Spechler","year":"2011","unstructured":"Spechler SJ, Sharma P, Souza RF, et al. American gastroenterological association technical review on the management of Barrett's esophagus. Gastroenterology. 2011;140:e18\u2013e52.","journal-title":"Gastroenterology"},{"key":"1135_CR10","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1136\/jclinpath-2011-200084","volume":"64","author":"LH Moyes","year":"2011","unstructured":"Moyes LH, Going JJ. Still waiting for predictive biomarkers in Barrett's oesophagus. J Clin Pathol. 2011;64:742\u201350.","journal-title":"J Clin Pathol"},{"key":"1135_CR11","first-page":"814146","volume":"2012","author":"A Bhardwaj","year":"2012","unstructured":"Bhardwaj A, McGarrity TJ, Stairs DB, et al. Barrett\u2019s esophagus: emerging knowledge and management strategies. Patholog Res Int. 2012;2012:814146.","journal-title":"Patholog Res Int."},{"key":"1135_CR12","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.3748\/wjg.v23.i28.5051","volume":"23","author":"C Amadi","year":"2017","unstructured":"Amadi C, Gatenby P. Barrett\u2019s oesophagus: current controversies. World J Gastroenterol. 2017;23:5051\u201367.","journal-title":"World J Gastroenterol"},{"key":"1135_CR13","first-page":"23","volume":"7","author":"C Gindea","year":"2014","unstructured":"Gindea C, Birla R, Hoara P, et al. Barrett esophagus: history, definition and etiopathogeny. J Med Life. 2014;7:23\u201330.","journal-title":"J Med Life"},{"key":"1135_CR14","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0096-5588(20)31275-7","volume":"21","author":"LH Bosher","year":"1951","unstructured":"Bosher LH, Taylor FH. Heterotopic gastric mucosa in the esophagus with ulceration and stricture formation. J Thorac Surg. 1951;21:306\u201312.","journal-title":"J Thorac Surg"},{"key":"1135_CR15","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/bjc.1952.14","volume":"6","author":"BC Morson","year":"1952","unstructured":"Morson BC, Belcher JR. Adenocarcinoma of the esophagus and ectopic gastric mucosa. Br J Cancer. 1952;6:127\u201330.","journal-title":"Br J Cancer"},{"key":"1135_CR16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/gutjnl-2013-305372","volume":"63","author":"RC Fitzgerald","year":"2014","unstructured":"Fitzgerald RC, di Pietro M, Ragunath K, British Society of Gastroenterology, et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus. Gut. 2014;63:7\u201342.","journal-title":"Gut"},{"key":"1135_CR17","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1572-0241.2008.01835.x","volume":"103","author":"KK Wang","year":"2008","unstructured":"Wang KK, Sampliner RE. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol. 2008;103:788\u201397.","journal-title":"Am J Gastroenterol"},{"key":"1135_CR18","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1055\/s-2007-966653","volume":"39","author":"J Boyer","year":"2007","unstructured":"Boyer J, Laugier R, Chemall M, et al. French society of digestive endoscopy SFED guideline: monitoring of patients with Barrett's esophagus. Endoscopy. 2007;39:840\u20132.","journal-title":"Endoscopy"},{"key":"1135_CR19","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/j.1572-0241.1998.00324.x","volume":"93","author":"P Sharma","year":"1998","unstructured":"Sharma P, Morales TG, Sampliner RE. Short segment Barrett's esophagus\u2014the need for standardization of the definition and of endoscopic criteria. Am J Gastroenterol. 1998;93:1033\u20136.","journal-title":"Am J Gastroenterol"},{"key":"1135_CR20","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.1572-0241.1999.990_m.x","volume":"940","author":"MA Eloubeidi","year":"1999","unstructured":"Eloubeidi MA, Provenzale D. Does this patient have Barrett\u2019s esophagus? The utility of predicting Barrett\u2019s esophagus at the index endoscopy. Am J Gastroenterol. 1999;940:937\u201343.","journal-title":"Am J Gastroenterol"},{"key":"1135_CR21","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0016-5085(99)70123-X","volume":"116","author":"WK Hirota","year":"1999","unstructured":"Hirota WK, Loughney TM, Lazas DJ, et al. Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. Gastroenterology. 1999;116:277\u201385.","journal-title":"Gastroenterology"},{"key":"1135_CR22","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/gutjnl-2015-309220","volume":"65","author":"H Pohl","year":"2016","unstructured":"Pohl H, Pech O, Arash H, et al. Length of Barrett\u2019s oesophagus and cancer risk: implications from a large sample of patients with early oesophageal adenocarcinoma. Gut. 2016;65:196\u2013201.","journal-title":"Gut"},{"key":"1135_CR23","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1007\/s10620-009-0985-z","volume":"55","author":"P Yachimski","year":"2010","unstructured":"Yachimski P, Lee RA, Tramontano A, et al. Secular trends in patients diagnosed with Barrett's esophagus. Dig Dis Sci. 2010;55:960\u20136.","journal-title":"Dig Dis Sci"},{"key":"1135_CR24","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1136\/gut.2008.163360","volume":"58","author":"DA Corley","year":"2009","unstructured":"Corley DA, Kubo A, Levin TR, et al. Race, ethnicity, sex and temporal differences in Barrett's oesophagus diagnosis: a large community-based study, 1994\u20132006. Gut. 2009;58:182\u20138.","journal-title":"Gut"},{"key":"1135_CR25","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1053\/j.gastro.2007.04.046","volume":"133","author":"DA Corley","year":"2007","unstructured":"Corley DA, Kubo A, Levin TR, et al. Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterology. 2007;133:34\u201341.","journal-title":"Gastroenterology"},{"key":"1135_CR26","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1007\/s10620-018-5161-x","volume":"63","author":"EJ Kuipers","year":"2018","unstructured":"Kuipers EJ, Spaander MC. Natural history of Barrett\u2019s esophagus. Dig Dis Sci. 2018;63:1997\u20132004.","journal-title":"Dig Dis Sci"},{"key":"1135_CR27","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1442-2050.2010.01054.x","volume":"23","author":"TJ Hayeck","year":"2010","unstructured":"Hayeck TJ, Kong CY, Spechler SJ, et al. The prevalence of Barrett\u2019s esophagus in the US: estimates from a simulation model confirmed by SEER data. Dis Esophagus. 2010;23:451\u20137.","journal-title":"Dis Esophagus"},{"key":"1135_CR28","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1572-0241.2005.40187.x","volume":"100","author":"M van Blankenstein","year":"2005","unstructured":"van Blankenstein M, Looman CWN, Johnston BJ, et al. Age and sex distribution of the prevalence of Barrett\u2019s esophagus found in a primary referral endoscopy center. Am J Gastroenterol. 2005;100:568\u201376.","journal-title":"Am J Gastroenterol"},{"key":"1135_CR29","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/j.cgh.2015.07.050","volume":"13","author":"S Shiota","year":"2015","unstructured":"Shiota S, Singh S, Anshasi A, et al. Prevalence of Barrett\u2019s esophagus in Asian countries: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2015;13:1907\u201318.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1135_CR30","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.gie.2014.01.009","volume":"79","author":"S Singh","year":"2014","unstructured":"Singh S, Manickam P, Amin AV, et al. Incidence of esophageal adenocarcinoma in Barrett\u2019s esophagus with low-grade dysplasia: a systematic review and meta-analysis. Gastrointest Endosc. 2014;79:897\u2013909.","journal-title":"Gastrointest Endosc"},{"key":"1135_CR31","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/bjc.2011.214","volume":"105","author":"CM den Hoed","year":"2011","unstructured":"den Hoed CM, van Blankenstein M, Dees J, et al. The minimal incubation period from the onset of Barrett\u2019s oesophagus to symptomatic adenocarcinoma. Br J Cancer. 2011;105:200\u20135.","journal-title":"Br J Cancer"},{"key":"1135_CR32","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1111\/j.1365-2036.2007.03528.x","volume":"26","author":"T Thomas","year":"2007","unstructured":"Thomas T, Abrams KR, De Caestecker JS, et al. Meta analysis: cancer risk in Barrett\u2019s oesophagus. Aliment Pharmacol Ther. 2007;26:1465\u201377.","journal-title":"Aliment Pharmacol Ther"},{"key":"1135_CR33","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1038\/ctg.2015.58","volume":"6","author":"Y Qiao","year":"2015","unstructured":"Qiao Y, Hyder A, Bae SJ, et al. Surveillance in patients with Barrett\u2019s esophagus for early detection of esophageal adenocarcinoma: a systematic review and meta-analysis. Clin Transl Gastroenterol. 2015;6:e131.","journal-title":"Clin Transl Gastroenterol"},{"key":"1135_CR34","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/ajg.2017.70","volume":"112","author":"BJ Qumseya","year":"2017","unstructured":"Qumseya BJ, Wani S, Gendy S, et al. Disease progression in Barrett\u2019s low-grade dysplasia with radiofrequency ablation compared with surveillance: systematic review and meta-analysis. Am J Gastroenterol. 2017;112:849\u201365.","journal-title":"Am J Gastroenterol"},{"issue":"956","key":"1135_CR35","first-page":"e1","volume":"14","author":"C Kestens","year":"2016","unstructured":"Kestens C, Offerhaus GJA, van Baal JWPM, et al. Patients with Barrett\u2019s esophagus and persistent low-grade dysplasia have an increased risk for high-grade dysplasia and cancer. Clin Gastroenterol Hepatol. 2016;14(956):e1\u2013962.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1135_CR36","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.cgh.2017.11.044","volume":"16","author":"R Krishnamoorthi","year":"2018","unstructured":"Krishnamoorthi R, Singh S, Ragunathan K, et al. Factors associated with progression of Barrett\u2019s esophagus: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2018;16:1046\u201355.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1135_CR37","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.1572-0241.2007.01746.x","volume":"103","author":"JE Abela","year":"2008","unstructured":"Abela JE, Going JJ, Mackenzie JF, et al. Systematic four-quadrant biopsy detects Barrett\u2019s dysplasia in more patients than nonsystematic biopsy. Am J Gastroenterol. 2008;103:850\u20135.","journal-title":"Am J Gastroenterol"},{"key":"1135_CR38","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/j.1572-0241.2007.01230.x","volume":"102","author":"R Harrison","year":"2007","unstructured":"Harrison R, Perry I, Haddadin W, et al. Detection of intestinal metaplasia in Barrett\u2019s esophagus: an observational comparator study suggests the need for a minimum of eight biopsies. Am J Gastroenterol. 2007;102:1154\u201361.","journal-title":"Am J Gastroenterol"},{"key":"1135_CR39","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1159\/000235923","volume":"80","author":"K Takubo","year":"2009","unstructured":"Takubo K, Vieth M, Aida J, et al. Differences in the definitions used for esophageal and gastric diseases in different countries: endoscopic definition of the esophagogastric junction, the precursor of Barrett's adenocarcinoma, the definition of Barrett's esophagus, and histologic criteria for mucosal adenocarcinoma or high-grade dysplasia. Digestion. 2009;80:248\u201357.","journal-title":"Digestion"},{"key":"1135_CR40","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1002\/1097-0142(20000601)88:11<2520::AID-CNCR13>3.0.CO;2-L","volume":"88","author":"A Ruol","year":"2000","unstructured":"Ruol A, Parenti A, Zaninotto G. Intestinal metaplasia is the probable common precursor of adenocarcinoma in barrett esophagus and adenocarcinoma of the gastric cardia. Cancer. 2000;88:2520\u20138.","journal-title":"Cancer"},{"key":"1135_CR41","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/gut.46.1.9","volume":"46","author":"P Sharma","year":"2000","unstructured":"Sharma P, Weston AP, Morales T, et al. Relative risk of dysplasia for patients with intestinal metaplasia in the distal oesophagus and in the gastric cardia. Gut. 2000;46:9\u201313.","journal-title":"Gut"},{"key":"1135_CR42","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/00000478-200604000-00001","volume":"30","author":"LC Lomo","year":"2006","unstructured":"Lomo LC, Blount PL, Sanchez CA, et al. Crypt dysplasia with surface maturation: a clinical, pathologic, and molecular study of a Barrett's esophagus cohort. Am J Surg Pathol. 2006;30:423\u201335.","journal-title":"Am J Surg Pathol"},{"key":"1135_CR43","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1365-2559.2007.02706.x","volume":"50","author":"M Kerkhof","year":"2007","unstructured":"Kerkhof M, Van Dekken H, Steyerberg EW, et al. Grading of dysplasia in Barrett's oesophagus: substantial interobserver variation between general and gastrointestinal pathologists. Histopathology. 2007;50:920\u20137.","journal-title":"Histopathology"},{"key":"1135_CR44","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1053\/hupa.2001.23510","volume":"32","author":"E Montgomery","year":"2001","unstructured":"Montgomery E, Bronner MP, Goldblum JR, et al. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. Hum Pathol. 2001;32:368\u201378.","journal-title":"Hum Pathol"},{"key":"1135_CR45","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/gut.47.2.251","volume":"47","author":"RJ Schlemper","year":"2000","unstructured":"Schlemper RJ, Riddell RH, Kato Y, et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut. 2000;47:251\u20135.","journal-title":"Gut"},{"key":"1135_CR46","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/ng1768","volume":"38","author":"CC Maley","year":"2006","unstructured":"Maley CC, Galipeau PC, Finley JC, et al. Genetic clonal diversity predicts progression to esophageal adenocarcinoma. Nat Genet. 2006;38:468\u201373.","journal-title":"Nat Genet"},{"key":"1135_CR47","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/ng.3013","volume":"46","author":"JM Weaver","year":"2014","unstructured":"Weaver JM, Ross-Innes CS, Shannon N, et al. Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis. Nat Genet. 2014;46:837\u201343.","journal-title":"Nat Genet"},{"key":"1135_CR48","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/ng.2591","volume":"45","author":"AM Dulak","year":"2013","unstructured":"Dulak AM, Stojanov P, Peng S, et al. Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity. Nat Genet. 2013;45:478\u201386.","journal-title":"Nat Genet"},{"key":"1135_CR49","doi-asserted-by":"crossref","first-page":"G278","DOI":"10.1152\/ajpgi.00092.2011","volume":"301","author":"X Huo","year":"2011","unstructured":"Huo X, Juergens S, Zhang X, et al. Deoxycholic acid causes DNA damage while inducing apoptotic resistance through NF-\u03baB activation in benign Barrett\u2019s epithelial cells. Am J Physiol Gastrointest Liver Physiol. 2011;301:G278\u2013G286286.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1135_CR50","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1136\/gut.50.4.451","volume":"50","author":"R Fitzgerald","year":"2002","unstructured":"Fitzgerald R, Onwuegbusi B, Bajaj-Elliott M, et al. Diversity in the oesophageal phenotypic response to gastro-oesophageal reflux: immunological determinants. Gut. 2002;50:451\u20139.","journal-title":"Gut"},{"key":"1135_CR51","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1111\/j.1572-0241.2005.41338.x","volume":"100","author":"J O\u2019Riordan","year":"2005","unstructured":"O\u2019Riordan J, Abdel-Latif M, Ravi N, et al. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation\u2013metaplasia\u2013dysplasia\u2013adenocarcinoma sequence in the esophagus. Am J Gastroenterol. 2005;100:1257\u201364.","journal-title":"Am J Gastroenterol"},{"key":"1135_CR52","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1111\/j.1572-0241.2001.04236.x","volume":"96","author":"BJ Reid","year":"2001","unstructured":"Reid BJ, Prevo LJ, Galipeau PC, et al. Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression. Am J Gastroenterol. 2001;96:2839\u201348.","journal-title":"Am J Gastroenterol"},{"key":"1135_CR53","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1136\/gut.2007.143339","volume":"57","author":"SJ Leedham","year":"2008","unstructured":"Leedham SJ, Preston SL, Mcdonald SA, et al. Individual crypt genetic heterogeneity and the origin of metaplastic glandular epithelium in human Barrett's oesophagus. Gut. 2008;57:1041\u20138.","journal-title":"Gut"},{"key":"1135_CR54","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1158\/0008-5472.CAN-11-3893","volume":"72","author":"AM Dulak","year":"2012","unstructured":"Dulak AM, Schumacher SE, Van Lieshout J, et al. Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis. Cancer Res. 2012;72:4383\u201393.","journal-title":"Cancer Res"},{"key":"1135_CR55","doi-asserted-by":"crossref","first-page":"5224","DOI":"10.1038\/ncomms6224","volume":"5","author":"K Nones","year":"2014","unstructured":"Nones K, Waddell N, Wayte N, et al. Genomic catastrophes frequently arise in esophageal adenocarcinoma and drive tumorigenesis. Nat Commun. 2014;5:5224.","journal-title":"Nat Commun"},{"key":"1135_CR56","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/ng.3343","volume":"47","author":"MD Stachler","year":"2015","unstructured":"Stachler MD, Taylor-Weiner A, Peng S, et al. Paired exome analysis of Barrett's esophagus and adenocarcinoma. Nat Genet. 2015;47:1047\u201355.","journal-title":"Nat Genet"},{"key":"1135_CR57","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/ng.2408","volume":"44","author":"Z Su","year":"2012","unstructured":"Su Z, Gay LJ, Strange A, et al. Common variants at the MHC locus and at chromosome 16q24. 1 predispose to Barrett\u2019s esophagus. Nat Genet. 2012;44:1131\u20136.","journal-title":"Nat Genet."},{"key":"1135_CR58","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/ng.2796","volume":"45","author":"DM Levine","year":"2013","unstructured":"Levine DM, Ek WE, Zhang R, et al. A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett\u2019s esophagus. Nat Genet. 2013;45:1487\u201393.","journal-title":"Nat Genet"},{"issue":"8","key":"1135_CR59","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1007\/s10620-018-5090-8","volume":"63","author":"WM Grady","year":"2018","unstructured":"Grady WM, Yu M. Molecular evolution of metaplasia to adenocarcinoma in the esophagus. Dig Dis Sci. 2018;63(8):2059\u201369.","journal-title":"Dig Dis Sci"},{"key":"1135_CR60","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0022-5223(19)37563-4","volume":"85","author":"TR Witt","year":"1983","unstructured":"Witt TR, Bains MS, Zaman MB, et al. Adenocarcinoma in Barrett\u2019s esophagus. J Thorac Cardiovasc Surg. 1983;85:337\u201345.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1135_CR61","first-page":"586","volume":"92","author":"AJ Cameron","year":"1997","unstructured":"Cameron AJ, Carpenter HA. Barrett\u2019s esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study. Am J Gastroenterol. 1997;92:586\u201391.","journal-title":"Am J Gastroenterol"},{"key":"1135_CR62","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q","volume":"6","author":"DP Slaughter","year":"1953","unstructured":"Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium. Cancer (Phila). 1953;6:963\u20138.","journal-title":"Cancer (Phila)"},{"key":"1135_CR63","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/carcin\/bgs301","volume":"34","author":"H He","year":"2013","unstructured":"He H, Tian D, Guo J, et al. DNA damage response in peritumoral regions of oesophageal cancer microenvironment. Carcinogenesis. 2013;34:139\u201345.","journal-title":"Carcinogenesis"},{"key":"1135_CR64","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/j.ajpath.2013.02.036","volume":"182","author":"J Somja","year":"2013","unstructured":"Somja J, Demoulin S, Roncarati P, et al. Dendritic cells in Barrett's esophagus carcinogenesis: an inadequate microenvironment for antitumor immunity? Am J Pathol. 2013;182:2168\u201379.","journal-title":"Am J Pathol"},{"key":"1135_CR65","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/path.4467","volume":"235","author":"TJ Underwood","year":"2015","unstructured":"Underwood TJ, Hayden AL, Derouet M, et al. Cancer-associated fibroblasts predict poor outcome and promote periostin-dependent invasion in oesophageal adenocarcinoma. J Pathol. 2015;235:466\u201377.","journal-title":"J Pathol"},{"key":"1135_CR66","first-page":"2292","volume":"54","author":"PL Blount","year":"1994","unstructured":"Blount PL, Galipeau PC, Sanchez CA, et al. 17p allelic losses in diploid cells of patients with Barrett\u2019s esophagus who develop aneuploidy. Cancer Res. 1994;54:2292\u20135.","journal-title":"Cancer Res"},{"key":"1135_CR67","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/0016-5085(94)90225-9","volume":"107","author":"R Hamelin","year":"1994","unstructured":"Hamelin R, Flejou JF, Muzeau F, et al. p53 gene mutations and p53 protein immunoreactivity in malignant and premalignant Barrett\u2019s esophagus. Gastroenterology. 1994;107:1012\u20138.","journal-title":"Gastroenterology"},{"key":"1135_CR68","first-page":"3406","volume":"55","author":"CM Gleeson","year":"1995","unstructured":"Gleeson CM, Sloan JM, McGuigan JA, et al. Base transitions at CpG dinucleotides in the p53 gene are common in esophageal adenocarcinoma. Cancer Res. 1995;55:3406\u201311.","journal-title":"Cancer Res"},{"key":"1135_CR69","first-page":"3320","volume":"59","author":"LJ Prevo","year":"1999","unstructured":"Prevo LJ, Sanchez CA, Galipeau PC, et al. p53-Mutant clones and field effects in Barrett\u2019s esophagus. Cancer Res. 1999;59:3320\u20138.","journal-title":"Cancer Res"},{"key":"1135_CR70","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/dote.12015","volume":"26","author":"MR Timmer","year":"2013","unstructured":"Timmer MR, Sun G, Gorospe EC, et al. Predictive biomarkers for Barrett\u2019s esophagus: so near and yet so far. Dis Esophagus. 2013;26:574\u201381.","journal-title":"Dis Esophagus"},{"key":"1135_CR71","doi-asserted-by":"crossref","first-page":"5669","DOI":"10.3748\/wjg.v16.i45.5669","volume":"16","author":"CA Ong","year":"2010","unstructured":"Ong CA, Lao-Sirieix P, Fitzgerald RC. Biomarkers in Barrett\u2019s esophagus and esophageal adenocarcinoma: predictors of progression and prognosis. World J Gastroenterol. 2010;16:5669\u2013811.","journal-title":"World J Gastroenterol"},{"key":"1135_CR72","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1136\/gutjnl-2017-314026","volume":"67","author":"H Chettouh","year":"2018","unstructured":"Chettouh H, Mowforth O, Galeano-Dalmau N, et al. Methylation panel is a diagnostic biomarker for Barrett\u2019s oesophagus in endoscopic biopsies and non-endoscopic cytology specimens. Gut. 2018;67:1942\u20139.","journal-title":"Gut"},{"key":"1135_CR73","first-page":"8284","volume":"61","author":"DJ Wong","year":"2001","unstructured":"Wong DJ, Paulson TG, Prevo LJ, et al. p16INK4a lesions are common, early abnormalities that undergo clonal expansion in Barrett\u2019s metaplastic epithelium. Cancer Res. 2001;61:8284\u20139.","journal-title":"Cancer Res"},{"key":"1135_CR74","doi-asserted-by":"crossref","first-page":"450","DOI":"10.4291\/wjgp.v5.i4.450","volume":"5","author":"YM Fouad","year":"2014","unstructured":"Fouad YM, Mostafa I, Yehia R, et al. Biomarkers of Barrett\u2019s esophagus. World J Gastrointest Pathophysiol. 2014;5:450\u20136.","journal-title":"World J Gastrointest Pathophysiol"},{"key":"1135_CR75","doi-asserted-by":"crossref","first-page":"78","DOI":"10.7861\/clinmedicine.14-6-s78","volume":"14","author":"S Zeki","year":"2014","unstructured":"Zeki S, Fitzgerald RC. Targeting care in Barrett's oesophagus. Clin Med (Lond). 2014;14:78\u201383.","journal-title":"Clin Med (Lond)"},{"key":"1135_CR76","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJM199903183401101","volume":"340","author":"J Lagergren","year":"1999","unstructured":"Lagergren J, Bergstrom R, Lindgren A, et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999;340:825\u201331.","journal-title":"N Engl J Med"},{"key":"1135_CR77","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/j.1572-0241.1998.00362.x","volume":"93","author":"RE Sampliner","year":"1998","unstructured":"Sampliner RE. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett\u2019s esophagus: the practice parameters committee of the American College of Gastroenterology. Am J Gastroenterol. 1998;93:1028\u201332.","journal-title":"Am J Gastroenterol"},{"key":"1135_CR78","unstructured":"National Institute for Health and Clinical Excellence (NICE). Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management. NICE. 2014. https:\/\/www.nice.org.uk\/guidance\/cg184\/chapter\/1-Recommendations#surveillance-for-people-with-barretts-oesophagus-2. Accessed 7 Nov 2019."},{"key":"1135_CR79","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/dc.10334","volume":"29","author":"RS Saad","year":"2003","unstructured":"Saad RS, Mahood LK, Clary KM. Role of cytology in the diagnosis of Barrett\u2019s esophagus and associated neoplasia. Diagn Cytopathol. 2003;29:130\u20135.","journal-title":"Diagn Cytopathol"},{"key":"1135_CR80","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0016-5107(97)70117-2","volume":"46","author":"JA Alexander","year":"1997","unstructured":"Alexander JA, Jones SM, Smith CJ. Usefulness of cytopathology and histology in the evaluation of Barrett\u2019s esophagus in a community hospital. Gastrointest Endosc. 1997;46:318\u201320.","journal-title":"Gastrointest Endosc"},{"key":"1135_CR81","doi-asserted-by":"crossref","first-page":"204062231983785","DOI":"10.1177\/2040622319837851","volume":"10","author":"V Sanghi","year":"2019","unstructured":"Sanghi V, Thota PN. Barrett's esophagus: novel strategies for screening and surveillance. Ther Adv Chronic Dis. 2019;10:2040622319837851.","journal-title":"Ther Adv Chronic Dis"},{"key":"1135_CR82","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.giec.2017.02.002","volume":"27","author":"J Offman","year":"2017","unstructured":"Offman J, Fitzgerald RC. Alternatives to traditional per-oral endoscopy for screening. Gastrointest Endosc Clin N Am. 2017;27:379\u201396.","journal-title":"Gastrointest Endosc Clin N Am"},{"key":"1135_CR83","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.gie.2012.01.029","volume":"75","author":"MK Shariff","year":"2012","unstructured":"Shariff MK, Bird-Lieberman EL, O\u2019Donovan M, et al. Randomized crossover study comparing efficacy of transnasal endoscopy with that of standard endoscopy to detect Barrett\u2019s esophagus. Gastrointest Endosc. 2012;75:954\u201361.","journal-title":"Gastrointest Endosc"},{"key":"1135_CR84","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1111\/j.1572-0241.2006.00890.x","volume":"101","author":"BA Jobe","year":"2006","unstructured":"Jobe BA, Chang HJG, EY. Office-based unsedated small-caliber endoscopy is equivalent to conventional sedated endoscopy in screening and surveillance for Barrett\u2019s esophagus: a randomized and blinded comparison. Am J Gastroenterol. 2006;101:2693\u2013703.","journal-title":"Am J Gastroenterol"},{"key":"1135_CR85","doi-asserted-by":"crossref","first-page":"e1001780","DOI":"10.1371\/journal.pmed.1001780","volume":"12","author":"CS Ross-Innes","year":"2015","unstructured":"Ross-Innes CS, Debiram-Beecham I, O\u2019Donovan M, et al. Evaluation of a minimally invasive cell sampling device coupled with assessment of trefoil factor 3 expression for diagnosing Barrett\u2019s esophagus: a multi-center case\u2013control study. PLoS Med. 2015;12:e1001780.","journal-title":"PLoS Med"},{"key":"1135_CR86","doi-asserted-by":"crossref","first-page":"c4372","DOI":"10.1136\/bmj.c4372","volume":"341","author":"SR Kadri","year":"2010","unstructured":"Kadri SR, Lao-Sirieix P, O\u2019Donovan M, et al. Acceptability and accuracy of a non-endoscopic screening test for Barrett\u2019s oesophagus in primary care: cohort study. BMJ. 2010;341:c4372.","journal-title":"BMJ"},{"issue":"1397\u20131404","key":"1135_CR87","first-page":"e7","volume":"15","author":"CR Heberle","year":"2017","unstructured":"Heberle CR, Omidvari AH, Ali A, et al. Cost effectiveness of screening patients with gastroesophageal reflux disease for Barrett\u2019s esophagus with a minimally invasive cell sampling device. Clin Gastroenterol Hepatol. 2017;15(1397\u20131404):e7.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1135_CR88","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/ajg.2009.86","volume":"104","author":"A Bhardwaj","year":"2009","unstructured":"Bhardwaj A, Hollenbeak CS, Pooran N, et al. A meta-analysis of the diagnostic accuracy of esophageal capsule endoscopy for Barrett\u2019s esophagus in patients with gastroesophageal reflux disease. Am J Gastroenterol. 2009;104:1533\u20139.","journal-title":"Am J Gastroenterol"},{"key":"1135_CR89","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s00535-015-1133-5","volume":"51","author":"P Bus","year":"2016","unstructured":"Bus P, Kestens C, Ten Kate FJW. Profiling of circulating microRNAs in patients with Barrett\u2019s esophagus and esophageal adenocarcinoma. J Gastroenterol. 2016;51:560\u201370.","journal-title":"J Gastroenterol"},{"key":"1135_CR90","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/ajg.2012.78","volume":"107","author":"KB Dunbar","year":"2012","unstructured":"Dunbar KB, Spechler SJ. The risk of lymph-node metastases in patients with high-grade dysplasia or intramucosal carcinoma in Barrett\u2019s esophagus: a systematic review. Am J Gastroenterol. 2012;107:850\u201362.","journal-title":"Am J Gastroenterol"},{"key":"1135_CR91","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1111\/j.1572-0241.1999.01276.x","volume":"94","author":"D Provenzale","year":"1999","unstructured":"Provenzale D, Schmitt C, Wong JB. Barrett\u2019s esophagus: a new look at surveillance based on emerging estimates of cancer risk. Am J Gastroenterol. 1999;94:2043\u201353.","journal-title":"Am J Gastroenterol"},{"key":"1135_CR92","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1111\/j.1572-0241.2006.00631.x","volume":"101","author":"S Hanna","year":"2006","unstructured":"Hanna S, Rastogi A, Weston AP, et al. Detection of Barrett\u2019s esophagus after endoscopic healing of erosive esophagitis. Am J Gastroenterol. 2006;101:1416\u201320.","journal-title":"Am J Gastroenterol"},{"key":"1135_CR93","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1136\/gutjnl-2014-308865","volume":"65","author":"HB El-Serag","year":"2016","unstructured":"El-Serag HB, Naik AD, Duan Z. Surveillance endoscopy is associated with improved outcomes of oesophageal adenocarcinoma detected in patients with Barrett\u2019s oesophagus. Gut. 2016;65:1252\u201360.","journal-title":"Gut"},{"key":"1135_CR94","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.giec.2017.02.005","volume":"27","author":"N Saxena","year":"2017","unstructured":"Saxena N, Inadomi JM. Effectiveness and cost-effectiveness of endoscopic screening and surveillance. Gastrointest Endosc Clin N Am. 2017;27:397\u2013421.","journal-title":"Gastrointest Endosc Clin N Am"},{"key":"1135_CR95","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1136\/gutjnl-2014-307197","volume":"64","author":"F Kastelein","year":"2015","unstructured":"Kastelein F, van Olphen S, Steyerberg EW, ProBar-study group, et al. Surveillance in patients with long-segment Barrett's oesophagus: a cost-effectiveness analysis. Gut. 2015;64:864\u201371.","journal-title":"Gut"},{"key":"1135_CR96","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1136\/gut.2009.176701","volume":"59","author":"PJ de Jonge","year":"2010","unstructured":"de Jonge PJ, Van Blankenstein M, Looman CW, et al. Risk of malignant progression in patients with Barrett\u2019s oesophagus: a Dutch nationwide cohort study. Gut. 2010;59:1030\u20136.","journal-title":"Gut"},{"key":"1135_CR97","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1053\/j.gastro.2015.04.013","volume":"149","author":"AJ Small","year":"2015","unstructured":"Small AJ, Araujo JL, Leggett CL, et al. Radiofrequency ablation is associated with decreased neoplastic progression in patients with Barrett\u2019s esophagus and confirmed low-grade dysplasia. Gastroenterology. 2015;149:567\u201376.","journal-title":"Gastroenterology"},{"key":"1135_CR98","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1572-0241.2007.01073.x","volume":"102","author":"A Srivastava","year":"2007","unstructured":"Srivastava A, Hornick JL, Li X, et al. Extent of low-grade dysplasia is a risk factor for the development of esophageal adenocarcinoma in Barrett\u2019s esophagus. Am J Gastroenterol. 2007;102:483\u201393.","journal-title":"Am J Gastroenterol"},{"key":"1135_CR99","doi-asserted-by":"crossref","first-page":"176","DOI":"10.7326\/0003-4819-138-3-200302040-00009","volume":"138","author":"JM Inadomi","year":"2003","unstructured":"Inadomi JM, Sampliner R, Lagergren J, et al. Screening and surveillance for Barrett esophagus in high-risk groups: a cost\u2013utility analysis. Ann Intern Med. 2003;138:176\u201386.","journal-title":"Ann Intern Med"},{"key":"1135_CR100","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1001\/jama.2014.2511","volume":"311","author":"KN Phoa","year":"2014","unstructured":"Phoa KN, van Vilsteren FG, Weusten B, et al. Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial. JAMA. 2014;311:1209\u201317.","journal-title":"JAMA"},{"key":"1135_CR101","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1053\/gast.2001.25111","volume":"120","author":"NS Buttar","year":"2001","unstructured":"Buttar NS, Wang KK, Sebo TJ, et al. Extent of high-grade dysplasia in Barrett\u2019s esophagus correlates with risk of adenocarcinoma. Gastroenterology. 2001;120:1630\u20139.","journal-title":"Gastroenterology"},{"key":"1135_CR102","first-page":"1","volume":"27","author":"V Pollit","year":"2018","unstructured":"Pollit V, Graham D, Leonard C, et al. A cost-effectiveness analysis of endoscopic eradication therapy (EET) for management of dysplasia arising in patients with Barrett's esophagus in the United Kingdom. Curr Med Res Opin. 2018;27:1\u201329.","journal-title":"Curr Med Res Opin"},{"key":"1135_CR103","first-page":"232","volume":"3","author":"CL Booth","year":"2012","unstructured":"Booth CL, Thompson KS. Barrett\u2019s esophagus: a review of diagnostic criteria, clinical surveillance practices and new developments. J Gastrointest Oncol. 2012;3:232\u201342.","journal-title":"J Gastrointest Oncol"},{"key":"1135_CR104","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.gie.2006.12.037","volume":"66","author":"BF Overholt","year":"2007","unstructured":"Overholt BF, Wang K, Burdick JS, et al. Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett\u2019s high-grade dysplasia. Gastrointest Endosc. 2007;66:460\u20138.","journal-title":"Gastrointest Endosc"},{"key":"1135_CR105","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1053\/j.gastro.2007.02.017","volume":"132","author":"GA Prasad","year":"2007","unstructured":"Prasad GA, Wang KK, Buttar NS, et al. Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett\u2019s esophagus. Gastroenterology. 2007;132:1226\u2013333.","journal-title":"Gastroenterology"},{"key":"1135_CR106","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1055\/s-2005-870433","volume":"37","author":"MA Kara","year":"2005","unstructured":"Kara MA, Peters FP, Rosmolen WD, et al. High-resolution endoscopy plus chromoendoscopy or narrow-band imaging in Barrett\u2019s esophagus: a prospective randomized crossover study. Endoscopy. 2005;37:929\u201336.","journal-title":"Endoscopy"},{"key":"1135_CR107","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1038\/ajg.2010.280","volume":"105","author":"J Pohl","year":"2010","unstructured":"Pohl J, Pech O, May A, et al. Incidence of macroscopically occult neoplasias in Barrett's esophagus: are random biopsies dispensable in the era of advanced endoscopic imaging? Am J Gastroenterol. 2010;105:2350\u20136.","journal-title":"Am J Gastroenterol"},{"key":"1135_CR108","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1365-2036.2006.02823.x","volume":"23","author":"PJ Fortun","year":"2006","unstructured":"Fortun PJ, Anagnostopoulos GK, Kaye P, et al. Acetic acid-enhanced magnification endoscopy in the diagnosis of specialized intestinal metaplasia, dysplasia and early cancer in Barrett's oesophagus. Aliment Pharmacol Ther. 2006;23:735\u201342.","journal-title":"Aliment Pharmacol Ther"},{"key":"1135_CR109","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.cgh.2010.06.016","volume":"8","author":"G Longcroft-Wheaton","year":"2010","unstructured":"Longcroft-Wheaton G, Duku M, Mead R, et al. Acetic acid spray is an effective tool for the endoscopic detection of neoplasia in patients with Barrett's esophagus. Clin Gastroenterol Hepatol. 2010;8:843\u20137.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1135_CR110","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1055\/s-2006-944974","volume":"38","author":"P Sharma","year":"2006","unstructured":"Sharma P, Marcon N, Wani S, et al. Non-biopsy detection of intestinal metaplasia and dysplasia in Barrett's esophagus: a prospective multicenter study. Endoscopy. 2006;38:1206\u201312.","journal-title":"Endoscopy"},{"key":"1135_CR111","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1136\/gut.52.1.24","volume":"52","author":"P Sharma","year":"2003","unstructured":"Sharma P, Weston AP, Topalovski M, et al. Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia in Barrett's oesophagus. Gut. 2003;52:24\u20137.","journal-title":"Gut"},{"key":"1135_CR112","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/qjmed\/hcs186","volume":"106","author":"PJ Trivedi","year":"2013","unstructured":"Trivedi PJ, Brade B. Indications, stains and techniques in chromoendoscopy. QJM. 2013;106:117\u201331.","journal-title":"QJM"},{"key":"1135_CR113","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.bpg.2005.08.003","volume":"20","author":"RS DaCosta","year":"2006","unstructured":"DaCosta RS, Wilson B, Marcon NE. Spectroscopy and fluorescence in esophageal diseases. Best Pract Res Clin Gastroenterol. 2006;20:41\u201357.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"1135_CR114","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0016-5107(04)02777-4","volume":"61","author":"MA Kara","year":"2005","unstructured":"Kara MA, Smits ME, Rosmolen WD, et al. A randomized crossover study comparing light-induced fluorescence endoscopy with standard videoendoscopy for the detection of early neoplasia in Barrett\u2019s esophagus. Gastrointest Endosc. 2005;61:671\u20138.","journal-title":"Gastrointest Endosc"},{"key":"1135_CR115","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1055\/s-2006-944726","volume":"38","author":"J Borovicka","year":"2006","unstructured":"Borovicka J, Fischer J, Neuweiler J, et al. Autofluorescence endoscopy in surveillance of Barrett\u2019s esophagus: a multicenter randomized trial on diagnostic efficacy. Endoscopy. 2006;38:867\u201372.","journal-title":"Endoscopy"},{"key":"1135_CR116","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1055\/s-0029-1243949","volume":"42","author":"J Mannath","year":"2010","unstructured":"Mannath J, Subramanian V, Hawkey CJ, et al. Narrow band imaging for characterization of high-grade dysplasia and specialized intestinal metaplasia in Barrett's esophagus: a meta-analysis. Endoscopy. 2010;42:351\u20139.","journal-title":"Endoscopy"},{"key":"1135_CR117","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1046\/j.1443-1661.2003.00239.x","volume":"15","author":"RS DaCosta","year":"2003","unstructured":"DaCosta RS, Wilson BC, Marcon NE. Photodiagnostic techniques for the endoscopic detection of premalignant gastrointestinal lesions. Dig Endosc. 2003;15:153\u201373.","journal-title":"Dig Endosc"},{"key":"1135_CR118","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jss.2015.02.045","volume":"195","author":"LY Robles","year":"2015","unstructured":"Robles LY, Singh S, Fisichella PM. Emerging enhanced imaging technologies of the esophagus: spectroscopy, confocal laser endomicroscopy and optical coherence tomography. J Surg Res. 2015;195:502\u201314.","journal-title":"J Surg Res"},{"key":"1135_CR119","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S1542-3565(05)00746-9","volume":"4","author":"JA Evans","year":"2006","unstructured":"Evans JA, Poneros JM, Bouma BE, et al. Optical coherence tomography to identify intramucosal carcinoma and high-grade dysplasia in Barrett\u2019s esophagus. Clin Gastroenterol Hepatol. 2006;4:38\u2013433.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1135_CR120","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1442-2050.2007.00660.x","volume":"20","author":"MA Kara","year":"2007","unstructured":"Kara MA, DaCosta RS, Streutker CJ, et al. Characterization of tissue autofluorescence in Barrett's esophagus by confocal fluorescence microscopy. Dis Esophagus. 2007;20:141\u201350.","journal-title":"Dis Esophagus"},{"key":"1135_CR121","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.gie.2005.11.049","volume":"64","author":"MA Kara","year":"2006","unstructured":"Kara MA, Ennahachi M, Fockens P, et al. Detection and classification of the mucosal and vascular patterns (mucosal morphology) in Barrett's esophagus by using narrow band imaging. Gastrointest Endosc. 2006;64:155\u201366.","journal-title":"Gastrointest Endosc"},{"key":"1135_CR122","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1053\/j.gastro.2008.01.003","volume":"134","author":"W Curvers","year":"2008","unstructured":"Curvers W, Baak L, Kiesslich R, et al. Chromoendoscopy and narrow-band imaging compared with high-resolution magnification endoscopy in Barrett's esophagus. Gastroenterology. 2008;134:670\u20139.","journal-title":"Gastroenterology"},{"key":"1135_CR123","doi-asserted-by":"crossref","unstructured":"Bhardwaj A, McGarrity TJ, Stairs DB, et al. Barrett\u2019s Esophagus: emerging knowledge and management strategies, Pathol Res Int. 2012:814146.","DOI":"10.1155\/2012\/814146"},{"key":"1135_CR124","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1111\/j.1572-0241.2002.06032.x","volume":"10","author":"M Skacel","year":"2002","unstructured":"Skacel M, Petras RE, Rybicki LA, et al. p53 expression in low grade dysplasia in Barrett\u2019s esophagus: correlation with interobserver agreement and disease progression. Am J Gastroenterol. 2002;10:2508\u201313.","journal-title":"Am J Gastroenterol"},{"key":"1135_CR125","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/j.1365-2559.2010.03715.x","volume":"57","author":"PV Kaye","year":"2010","unstructured":"Kaye PV, Haider SA, James PD, et al. Novel staining pattern of p53 in Barrett\u2019s dysplasia\u2014the absent pattern. Histopathology. 2010;57:933\u20135.","journal-title":"Histopathology"},{"key":"1135_CR126","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/path.1884","volume":"208","author":"G Cl\u00e9ment","year":"2006","unstructured":"Cl\u00e9ment G, Braunschweig R, Pasquier N, et al. Methylation of APC, TIMP3, and TERT: a new predictive marker to distinguish Barrett\u2019s oesophagus patients at risk for malignant transformation. J Pathol. 2006;208:100\u20137.","journal-title":"J Pathol"},{"key":"1135_CR127","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/S0016-5085(98)70016-2","volume":"115","author":"B Klump","year":"1998","unstructured":"Klump B, Hsieh CJ, Holzmann K, et al. Hypermethylation of the CDKN2\/p16 promoter during neoplastic progression in Barrett\u2019s esophagus. Gastroenterology. 1998;115:1381\u20136.","journal-title":"Gastroenterology"},{"key":"1135_CR128","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/8816","volume":"22","author":"MT Barrett","year":"1999","unstructured":"Barrett MT, Sanchez CA, Prevo LJ, et al. Evolution of neoplastic cell lineages in Barrett oesophagus. Nat Genet. 1999;22:106\u20139.","journal-title":"Nat Genet"},{"key":"1135_CR129","doi-asserted-by":"crossref","first-page":"e020427","DOI":"10.1136\/bmjopen-2017-020427","volume":"8","author":"T Nieto","year":"2018","unstructured":"Nieto T, Tomlinson CL, Dretzke J, et al. A systematic review of epigenetic biomarkers in progression from non-dysplastic Barrett's oesophagus to oesophageal adenocarcinoma. BMJ Open. 2018;8:e020427.","journal-title":"BMJ Open"},{"key":"1135_CR130","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1038\/s41596-019-0150-x","volume":"14","author":"CLM Morais","year":"2019","unstructured":"Morais CLM, Paraskevaidi M, Cui L, et al. Standardization of complex biologically derived spectrochemical datasets. Nat Protoc. 2019;14:1546\u201377.","journal-title":"Nat Protoc"},{"key":"1135_CR131","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1039\/c2an16300d","volume":"137","author":"J Trevisan","year":"2012","unstructured":"Trevisan J, Angelov PP, Carmichael PL, et al. Extracting biological information with computational analysis of Fourier-transform infrared (FTIR) biospectroscopy datasets: current practices to future perspectives. Analyst. 2012;137:3202\u201315.","journal-title":"Analyst"},{"issue":"3\u20134","key":"1135_CR132","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/jbio.201400018","volume":"7","author":"AL Mitchell","year":"2014","unstructured":"Mitchell AL, Gajjar KB, Theophilou G, et al. Vibrational spectroscopy of biofluids for disease screening or diagnosis: translation from the laboratory to a clinical setting. J Biophotonics. 2014;7(3\u20134):153\u201365.","journal-title":"J Biophotonics"},{"key":"1135_CR133","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1039\/C6AN01871H","volume":"142","author":"OJ Old","year":"2017","unstructured":"Old OJ, Lloyd GR, Nallala J, et al. Rapid infrared mapping for highly accurate automated histology in Barrett's oesophagus. Analyst. 2017;142:1227\u2013344.","journal-title":"Analyst"},{"key":"1135_CR134","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.gie.2013.05.028","volume":"79","author":"LM Almond","year":"2014","unstructured":"Almond LM, Hutchings J, Lloyd G, et al. Endoscopic Raman spectroscopy enables objective diagnosis of dysplasia in Barrett's esophagus. Gastrointest Endosc. 2014;79:37\u201345.","journal-title":"Gastrointest Endosc"},{"key":"1135_CR135","doi-asserted-by":"crossref","first-page":"103","DOI":"10.7785\/tcrt.2012.500185","volume":"10","author":"MS Bergholt","year":"2011","unstructured":"Bergholt MS, Zheng W, Lin K, et al. In vivo diagnosis of esophageal cancer using image-guided Raman endoscopy and biomolecular modeling. Technol Cancer Res Treat. 2011;10:103\u201312.","journal-title":"Technol Cancer Res Treat"},{"key":"1135_CR136","doi-asserted-by":"crossref","first-page":"7447","DOI":"10.1039\/C9AN01749F","volume":"144","author":"I Maitra","year":"2019","unstructured":"Maitra I, Morais CLM, Lima KMG, et al. Attenuated total reflection Fourier-transform infrared spectral discrimination in human bodily fluids of oesophageal transformation to adenocarcinoma. Analyst. 2019;144:7447\u2013566.","journal-title":"Analyst"},{"key":"1135_CR137","doi-asserted-by":"crossref","unstructured":"Maitra I, Morais CLM, Lima KMG, et al. Raman spectral discrimination in human liquid biopsies of oesophageal transformation to adenocarcinoma. J Biophotonics. 2019:e201960132","DOI":"10.1002\/jbio.201960132"},{"issue":"4","key":"1135_CR138","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/flgastro-2016-100712","volume":"7","author":"D Graham","year":"2016","unstructured":"Graham D, Lipman G, Sehgal V, et al. Monitoring the premalignant potential of Barrett's oesophagus. Frontline Gastroenterol. 2016;7(4):316\u201322.","journal-title":"Frontline Gastroenterol"},{"key":"1135_CR139","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/jnci\/djr203","volume":"103","author":"S Bhat","year":"2011","unstructured":"Bhat S, Coleman HG, Yousef F, et al. Risk of malignant progression in Barrett's Esophagus patients: results from a large population-based study. J Natl Cancer Inst. 2011;103:1049\u201357.","journal-title":"J Natl Cancer Inst"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-020-01135-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12328-020-01135-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-020-01135-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T00:12:49Z","timestamp":1622679169000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12328-020-01135-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,3]]},"references-count":139,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["1135"],"URL":"https:\/\/doi.org\/10.1007\/s12328-020-01135-2","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"type":"print","value":"1865-7257"},{"type":"electronic","value":"1865-7265"}],"subject":[],"published":{"date-parts":[[2020,6,3]]},"assertion":[{"value":"7 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"IM and RSD do not declare any conflicts of interest (financial, professional or personal). FLM is joining Biocel Ltd. This company has subsidiaries developing instrumentation and analytical techniques for vibrational spectroscopy in a range of applications, including clinical.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}